CNBC: New year, new investing strategy?

EquityZen

|

December 23, 2015

Company News

EquityZen's managed fund offering is featured by CNBC as a tool for accredited investors to diversify their exposure to private technology companies.

Related Posts

Investors Shareholders Insights

EquityZen | July 11, 2024

Investing Pre-IPO: What Investors Need to Know to Navigate the Market

In this video, Brianne Lynch and Phil Haslett discuss what investors should consider when investing in the pre-IPO...

Company News

EquityZen | May 24, 2021

Bloomberg: Phil Haslett on Bloomberg Quicktake- SPACs vs IPOs

What do companies think about SPACs vs. traditional IPOs? Catch EquityZen's Phil Haslett on Bloomberg sharing his...

Company News

EquityZen | August 24, 2018

Institutional Investor: Can SoftBank Really Meet Investors' Expectations?

Institutional Investor features EquityZen's research on SoftBank's $100 billion Vision Fund in their latest piece.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2023 EquityZen. All rights reserved.